Cisplatin - Perfection · 2020. 6. 30. · 1 mM 3.3328 mL 166.6.663639 99 mmLm 33.3278 mL 5 mM 0.66...

3
1 | www.apexbt.com Cisplatin Cat. No.: A8321 CAS No.: 15663-27-1 Formula: Cl2H6N2Pt M.Wt: 300.05 Synonyms: CDDP Target: Apoptosis Pathway: Caspase Storage: Store at RTIt is recommended to store in the form of powder in the dark, the solution is very unstable (Prepare Solution fresh and use at room temperature), DMF is recommended, DMSO can inactivate Cisplatin's activity. In Vitro ı15.0mg/mL in DMSO, ı12.5mg/mL in DMF,insoluble in EtOH,insoluble in H2O Preparing Stock Solutions Mass 1mg 5mg 10mg Solvent Concentration 1 mM 3.3328 mL 16.6639 mL 33.3278 mL 5 mM 0.6666 mL 3.3328 mL 6.6656 mL 10 mM 0.3333 mL 1.6664 mL 3.3328 mL Please refer to the solubility information to select the appropriate solvent. Shortsummary Inhibits DNA synthesis,chemotherapy drug IC₅₀ & Target In Vitro Cell Viability Assay Cell Line: L1210/0 cells Preparation method˖ The solubility of this compound in DMF is >12.5 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Product Name: Cisplatin Revision Date: 01/10/2020 Product Data Sheet Solvent & Solubility Biological Activity 1 | www.apexbt.com Cisplatin Cat. No.: A832 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 CAS No.: 15 15 5 5 15 5 5 5 15 15 15 15 1 15 15 5 15 1566 66 66 66 66 66 66 66 66 663 3 3 3 3 3 3 3 3 3 3 - - - - - - - 27 27 27 27 27 27 27 27 27 27 27 7 2 2 - 1 Formula: Cl C Cl Cl Cl Cl C C Cl Cl C Cl Cl C C 2 2 2H 2 2 2 2 2 6N2Pt M.Wt: 300.05 Synonyms: CDDP T arget: Apoptosis Pathway: Caspase Storage: Store at RTIt is recommended d to store in the form of powder r r r r r i i i i in the dark, th e solution is very unstable ( ( ( ( ( ( ( ( ( ( Pr Pr Pr Pr Pr Pr Pr Pr Pr Pr Prep ep ep ep ep ep ep ep ep ep epar ar ar ar ar ar ar ar ar a ar a e e e e e e e e e e e e e e So S S S S S S S S lution fre esh and use at ro o o o o o o oom om om om om om om m m om m om om t t t t t t t t t tem em em em em m m m m m em em m em em m m em m mp p p p pe pe pe pe pe pe p p pe pe p pe pe pe e e p p ra ra ra ra ra ra ra ra ra r ture), DMF is re ecommended, DM DM DM DM DM M DM DM DM M DM D SO SO SO SO SO SO SO SO SO SO SO SO SO O can inactivate Cisplatin's activity n's activity . In Vitro ı 15.0mg/mL in DMSO, ı 12.5mg/mL in DMF,insoluble in EtOH,insoluble in H2O Preparing Stock Solu u u u u uti ti ti t ti ti ti t t ti ion on on on on on n on n on o o s s s s s s s s s s s Mass 1mg 5mg 10mg Solvent Concentration 1 mM 3.3328 mL 16 16 16 16 16 16 6 16 6 6 6.6 .6 .6 .6 6 6 .6 .6 .6 .6 . . . . . . 63 63 63 63 63 63 63 63 63 63 63 63 63 63 3 63 63 63 39 9 9 9 9 9 9 9 9 9 9 m m m mL mL m m m mL m m m m 33.3278 mL 5 mM 0.6666 mL 3. 3. 3. 3. 3. 3. 3 3. 3. 3. 3. 3. 3 3 3 33 3 3 3 3 3 3 3 3 3 3 28 mL 6.6656 mL 1 0 mM 0.3333 mL mL mL mL mL mL mL mL L mL mL L mL mL mL L L 1.6664 mL 3.3328 mL Please refer to the solubility information to select the appropriate solvent. Shortsummary Inhibits DNA A A A A A A A A A s s s s s s s syn yn yn yn yn yn yn yn yn yn y y th t t t t esis,chemotherapy drug IC ₅₀ & Target In Vitro Ce Ce Ce Ce Ce Ce Ce Ce Ce Ce Ce ell ll ll ll l ll ll ll ll l l l V V V V V V V V V V V V Via ia i ia ia ia i i i i bility Assay Cell Line: L1210/0 cells Preparation method ˖ The solubility of this compound in DMF is >12.5 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Product Name : Cisplatin Revision Date: 0 1 / 1 0 / 0 20 20 et Product Data Shee Solvent & Solubility Biological Activity

Transcript of Cisplatin - Perfection · 2020. 6. 30. · 1 mM 3.3328 mL 166.6.663639 99 mmLm 33.3278 mL 5 mM 0.66...

  • 1 | www.apexbt.com

    CisplatinCat. No.: A8321

    CAS No.: 15663-27-1

    Formula: Cl2H6N2Pt

    M.Wt: 300.05

    Synonyms: CDDP

    Target: Apoptosis

    Pathway: Caspase

    Storage: Store at RTIt is recommended to store in the

    form of powder in the dark, the solution is very

    unstable (Prepare Solution fresh and use at

    room temperature), DMF is recommended,

    DMSO can inactivate Cisplatin's activity.

    In Vitro

    15.0mg/mL in DMSO, 12.5mg/mL in DMF,insoluble in EtOH,insoluble in H2O

    Preparing

    Stock Solutions

    Mass

    1mg 5mg 10mgSolvent

    Concentration

    1 mM 3.3328 mL 16.6639 mL 33.3278 mL

    5 mM 0.6666 mL 3.3328 mL 6.6656 mL

    10 mM 0.3333 mL 1.6664 mL 3.3328 mL

    Please refer to the solubility information to select the appropriate solvent.

    Shortsummary Inhibits DNA synthesis,chemotherapy drug

    IC₅₀ & TargetIn Vitro

    Cell Viability Assay

    Cell Line: L1210/0 cells

    Preparation method The solubility of this compound in DMF is >12.5 mM. General tips for obtaining

    a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or

    shake it in the ultrasonic bath for a while.

    Product Name: CisplatinRevision Date: 01/10/2020

    Product Data Sheet

    Solvent & Solubility

    Biological Activity

    1 | www.apexbt.com

    CisplatinCat. No.: A832222222222111111111

    CAS No.: 15155515555151515151151551515666666666666666666666333333333333-------2727272727272727272727722 -1

    Formula: ClCClClClClCCClClCClClCC 222H22222 6N2Pt

    M.Wt: 300.05

    Synonyms: CDDP

    Target: Apoptosis

    Pathway: Caspase

    Storage: Store at RTIt is recommendedd to store in the

    form of powderrrrrr iiiiin the dark, the solution is very

    unstable (((((((((((PrPrPrPrPrPrPrPrPrPrPrepepepepepepepepepepeparararararararararaara eeeeeeeeeeeeee SoSSSSSSSS lution freesh and use at

    rooooooooomomomomomomommmommomom ttttttttttemememememmmmmmememmememmmemmmpppppepepepepepepppepeppepepeeepp rararararararararar ture), DMF is reecommended,

    DMDMDMDMDMMDMDMDMMDMD SOSOSOSOSOSOSOSOSOSOSOSOSOO can inactivate Cisplatin's activityn's activity.

    In Vitro

    15.0mg/mL in DMSO, 12.5mg/mL in DMF,insoluble in EtOH,insoluble in H2O

    Preparing

    Stock Soluuuuuutititittitititttiiononononononnonnonoo sssssssssss

    Mass

    1mg 5mg 10mgSolvent

    Concentration

    1 mM 3.3328 mL 161616161616616666.6.6.6.666.6.6.6.6...... 6363636363636363636363636363363636339 9 99 99 9 9 9 99 mmmmLmLmmmmLmmmm 33.3278 mL

    5 mM 0.6666 mL 3.3.3.3.3.3.33.3.3.3.3.333 333333333333 28 mL 6.6656 mL

    10 mM 0.3333 mLmLmLmLmLmLmLmLLmLmLLmLmLmLLL 1.6664 mL 3.3328 mL

    Please refer to the solubility information to select the appropriate solvent.

    Shortsummary Inhibits DNAAAAAAAAAAA ssssssssynynynynynynynynynynyy thtttt esis,chemotherapy drug

    IC₅₀ & TargetIn Vitro

    CeCeCeCeCeCeCeCeCeCeCeellllllllllllllllllll VVVVVVVVVVVVViaiaiiaiaiaiiii bility Assay

    Cell Line: L1210/0 cells

    Preparation method The solubility of this compound in DMF is >12.5 mM. General tips for obtaining

    a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or

    shake it in the ultrasonic bath for a while.

    Product Name: CisplatinpRevision Date: 01/10/ 02020

    etProduct Data Shee

    Solvent & Solubility

    Biological Activity

  • 2 | www.apexbt.com

    Reacting conditions: 0, 0.5, 1, 2, 4 and 8 μg/mL; 2 hrs

    Applications: At low concentrations, Cisplatin induced minimal cell death. At higher

    concentrations, cell death was obvious with only 4% viability. By 10 days after

    incubation, these few survivors begun to grow and became the predominant

    cells in the population.

    In Vivo

    Animal experiment

    Animal models: Nude mice bearing human ovarian cancer OVCAR-3 cell xenografts

    Dosage form: 5 mg/kg, i.v.; at day 0 and day 7

    Applications: Cisplatin (5 mg/kg) given at the day 0 and 7 induced a tumor growth inhibition

    (GI) (85.1%) of the OVCAR-3 cell xenografts.

    Other notes: Please test the solubility of all compounds indoor, and the actual solubility may

    slightly differ with the theoretical value. This is caused by an experimental

    system error and it is normal.

    1. Chen Z, Tian D, et al. "Apigenin Combined With Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through

    Inhibition of HIF-1α, c-Myc, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-Mutated H1975 Cells." Front Pharmacol.

    2019 Mar 22;10:260.PMID:30967777

    2. Zhang B, Cui B, et al. "ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human

    nasopharyngeal carcinoma." Cancer Manag Res. 2019 Jan

    9;11:573-585.PMID:30666155

    3. Wu Q, Wei X, et al. "Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening." Biomed Microdevices.

    2018 Sep 15;20(4):82.PMID:30220069

    4. Yeo SK, Paul R, et al. "Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of

    BRCA1-deficient breast cancer." Autophagy. 2018;14(7):1214-1225.PMID:29938573

    5. Sharma K, Vu TT, et al. "p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell

    carcinoma cells." Mol Oncol. 2018 Jan 19.PMID:29352505

    See more customer validations on www.apexbt.com.

    [1]. Sorenson CM, Eastman A. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA

    double-strand breaks. Cancer Res. 1988 Aug 15;48(16):4484-8.

    [2]. Molthoff CF, Pinedo HM, Schlüper HM, Rutgers DH, Boven E. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin,

    cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts. Int J Cancer. 1992 Apr

    22;51(1):108-15.

    FOR RESEARCH PURPOSES ONLY.NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.

    Product Citations

    References

    Caution

    2 | www.apeexbt.com

    Reacting conditions: 0, 0.5, 1, 2, 4 and 8 μg/mL; 2 hrs

    Applications: At low concentrations, Cisplatin induced minimal cell death. At higher

    concentrations, cell death was obvious with only 4% viability. By 10 days after

    incubation, these few survivors begun to grow and became the predominant

    cells in the population.

    In Vivo

    Animal exxxxxxxxpepepepepepepepepepepeririririririririririimememememememememememem ntntntntntntntntntntntntntttn

    Animmmmmmmmmmmalalalalalalalallalal mmmmmmmmmmodododododododododododododdodoododooddeleleleleelelelellelelee ss: Nude mice bearing human ovarian cancerrrrrrrrrr OOOOOOOOOOOVCVCVCVCVCVCVCVCVCVCV ARAAAAARARARARAARARARARARARARAR----------33333333333 cell xenografts

    DoooDoDooooDDDDDDDDoDDDD sasasasasasasasasasasagegegegegegegggegg form: 5 mg/kg, i.v.; at day 0 and day 7

    AAAAAAApAAAA plications: Cisplatin (5 mg/kg) given at the day 0000000000000 and 7 induced a tumor growth inhibition

    (GI) (85.1%) of the OVCAR-3 cell xenografts.

    Other notes: Please test the solubility of all compounds indoor, and the actual solubility may

    slightly differ with the theoretical value. This is caused by an experimental

    system error and it is normal.

    1. Chen Z, Tian D,D,D,DD,D,D,D,D,,, eeeeett ttttttt alalaalalalalaala . . .. .. "A"A"A"A"A"A"A"A"A"A"AAApipippppipipppp genin Combined With Gefitinib Blocks Autophagy Flux and Innnnnnnnnnnduuuuduuuuuddd cecececececececeececes s ss ss s s s s ApApApApApApApApApApAAppA optotic Cell Death Through

    Inhibition of HIF--1α1α1α1α1αα1α1α1α1α1α1α1α1α1α,,,,,,,,,,,,,, ccccccccccccccc-------MMyMMMMMMMMMMMM c, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-MuMuMuMuMuMuMuMuMuMuMuMuMuMuMuMMutatatatatatatatatatatatatataatetetetteteeeeetteteteteetttet d dddddddddd H1975 Cells." Front Pharmacol.

    2019 Mar 22;10:260.PMID:30967777

    2. Zhang B, Cui B, et al. "ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human

    nasopharyngeal carcinoma." Cancer Manag Res. 2019 Jan

    9;11:573-585.PMID:30666155

    3. Wu Q, Wei X, et al. "Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening." Biomed Microdevices.

    2018 Sep 15;20(4):82.PMID:30220069

    4. Yeo SK, Paul R, et al. "Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagygygygygygygygygygyg in a mouse model of

    BRCA1-deficient breast cancer." AuAuuuuuuutotototototototototooophphphphphphphphphphagy. 2018;14(7):1214-1225.PMID:29938573

    5. Sharma K, Vu TT, et al. "p53--inininininininniniiii dedededededededdedeeepepepepepepepepepepeendndndndndndndndnnddndent Noxa induction by cisplatin is regulated by ATF3/ATFTFFFFFFFFFFFF44444 44 4444 inininininininininn hhhhhhhhhheaeeaeeaeaeaeaaeaeaeaeaeaeeaeaaeaad ddd dddddddddddd aanaa d neck squamous cell

    carcinoma cells." Mol Onnnnnnnnnnncococococococococococool.l.l.l.l.l.l.l 2222222222201010101010101010010010100101010100100018 8 8 88888888 888 JaJJJJJJJ n 19.PMID:29352505

    See more custototoototototototooototoomeeeeeemeememmmmmmmmmm rrrrrrr rr vavavavavavavavavavavavavalilililililililililililidddadd tions on www.apexbt.com.

    [1]. Sorenson CM, Eastman A. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA

    double-strand breaks. Cancer Res. 1988 Aug 15;48(16):4484-8.

    [2]. Molthoff CF, Pinedo HM, Schlüpepepepepepepepepeeep r r r r rr r r rrr HMHH , Rutgers DH, Boven E. Comparison of 131I-labelled anttttttttti-epepepepepepepepeppeeeeeee isisisissisisisisisisiaiaiaiaiaiaiaaiaaalililililillililililinnnnnnnnnnn 1131111111111 9H2 with cisplatin,

    cyclophosphamide or external-bebebebebebebebeebeamamamamamamamamamamamm rrrrrrrrrrrradadadadadadadadadaddadadadiiiaii tion for anti-tumor efficacy in human ovarian cancerrrrrrrrr xxxxxxxxxxenenenenenenenennnene ogogogogogogggggoggogogogoggggrrrrararararararrarararaararar ftftftftftftftftftftftf s. Int J Cancer. 1992 Apr

    22;51(1):108-15.

    FOR RESEARCH PURPOSES ONLY.NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTTIC USE.

    Product Citationssssssss

    References

    Caution

  • 3 | www.apexbt.com

    Specific storage and handling information for each product is indicated on the product datasheet. Most APExBIO products are stable

    under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage

    temperature. Shortterm storage of many products are stable in the short-term at temperatures that differ from that required for

    long-term storage. We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt

    of the product, follow the storage recommendations on the product data sheet.

    APExBIO Technologywww.apexbt.com

    7505 Fannin street, Suite 410, Houston, TX 77054. Tel: +1-832-696-8203 | Fax: +1-832-641-3177 | Email: [email protected]

    3 | www.apexbt.com

    Specific storage and handling information for each product is indicated on the product datasheet. Most APExBEE IO products are stable

    under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage

    temperature. Shortterm storage of many products are stable in the short-term at temperatures that differ from that required for

    long-term storage. We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt

    of the product, follow the storage recommendations on the product data sheet.

    APExBIO Technologywww.apexbt.com

    7505 Fannin street, Suite 410, Houston, TX 77054.Tel: +1-832-696-8203 | Fax: +1-832-641-3177 | Email: [email protected]